Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis

Vineshkumar Thidil Puliyappadamba, Wenjuan Wu, Debra Bevis, Liyue Zhang, Lisa Polin, Robert Kilkuskie, Russell L. Finley, Scott D. Larsen, Edi Levi, Fred R. Miller, Anil Wali, Arun K. Rishi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

CARP-1/CCAR1, a perinuclear phosphoprotein, is a regulator of cell growth and apoptosis signaling. Although CARP-1 is a regulator of chemotherapy- dependent apoptosis, it is also a part of the NF-κB proteome and a co-activator of steroid/thyroid nuclear receptors as well as β-catenin signaling. Our yeast two-hybrid screen revealed CARP-1 binding with the anaphase-promoting complex/cyclosome E3 ubiquitin ligase component APC-2 protein. CARP-1 also binds with anaphase-promoting complex/cyclosome co-activators Cdc20 and Cdh1. Following mapping of the minimal epitopes involved in CARP-1 binding with APC-2, a fluorescence polarization assay was established that indicated a dissociation constant (K d) of 480 nM for CARP-1/APC-2 binding. Fluorescence polarization assay-based high throughput screening of a chemical library yielded several small molecule antagonists of CARP-1/APC-2 binding, termed CARP-1 functional mimetics. CFM-4 (1(2-chlorobenzyl)-5′-phenyl-3′H-spiro[indoline-3,2′-[1,3,4] thiadiazol]-2-one), a lead compound, binds with and stimulates CARP-1 expression. CFM-4 prevents CARP-1 binding with APC-2, causes G 2M cell cycle arrest, and induces apoptosis with an IC 50 range of 10-15 μM. Apoptosis signaling by CFM-4 involves activation of caspase-8 and -9 and caspase-mediated ubiquitin-proteasome pathway-independent loss of cyclin B1 and Cdc20 proteins. Depletion of CARP-1, however, interferes with CFM-4-dependent cell growth inhibition, activation of caspases, and apoptosis. Because CFM-4 also suppresses growth of drug-resistant human breast cancer cells without affecting the growth of human breast epithelial MCF-10A cells, elevating CARP-1 by CFM-4 and consequent apoptosis could in principle be exploited to further elucidate, and perhaps effectively target, often deregulated cell cycle pathways in pathological conditions, including cancer.

Original languageEnglish (US)
Pages (from-to)38000-38017
Number of pages18
JournalJournal of Biological Chemistry
Volume286
Issue number44
DOIs
StatePublished - Nov 4 2011

Fingerprint

Anaphase-Promoting Complex-Cyclosome
Cell Cycle Proteins
Apoptosis Regulatory Proteins
Cell growth
Apoptosis
Growth
Protein Binding
Fluorescence Polarization
Cells
Caspases
Cdc20 Proteins
Assays
Fluorescence
Chemical activation
Polarization
High-Throughput Screening Assays
Small Molecule Libraries
Lead compounds
Cyclin B1
Epitope Mapping

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis. / Puliyappadamba, Vineshkumar Thidil; Wu, Wenjuan; Bevis, Debra; Zhang, Liyue; Polin, Lisa; Kilkuskie, Robert; Finley, Russell L.; Larsen, Scott D.; Levi, Edi; Miller, Fred R.; Wali, Anil; Rishi, Arun K.

In: Journal of Biological Chemistry, Vol. 286, No. 44, 04.11.2011, p. 38000-38017.

Research output: Contribution to journalArticle

Puliyappadamba, Vineshkumar Thidil ; Wu, Wenjuan ; Bevis, Debra ; Zhang, Liyue ; Polin, Lisa ; Kilkuskie, Robert ; Finley, Russell L. ; Larsen, Scott D. ; Levi, Edi ; Miller, Fred R. ; Wali, Anil ; Rishi, Arun K. / Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 44. pp. 38000-38017.
@article{b79de44bbfd1461c92775dc415f3e894,
title = "Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis",
abstract = "CARP-1/CCAR1, a perinuclear phosphoprotein, is a regulator of cell growth and apoptosis signaling. Although CARP-1 is a regulator of chemotherapy- dependent apoptosis, it is also a part of the NF-κB proteome and a co-activator of steroid/thyroid nuclear receptors as well as β-catenin signaling. Our yeast two-hybrid screen revealed CARP-1 binding with the anaphase-promoting complex/cyclosome E3 ubiquitin ligase component APC-2 protein. CARP-1 also binds with anaphase-promoting complex/cyclosome co-activators Cdc20 and Cdh1. Following mapping of the minimal epitopes involved in CARP-1 binding with APC-2, a fluorescence polarization assay was established that indicated a dissociation constant (K d) of 480 nM for CARP-1/APC-2 binding. Fluorescence polarization assay-based high throughput screening of a chemical library yielded several small molecule antagonists of CARP-1/APC-2 binding, termed CARP-1 functional mimetics. CFM-4 (1(2-chlorobenzyl)-5′-phenyl-3′H-spiro[indoline-3,2′-[1,3,4] thiadiazol]-2-one), a lead compound, binds with and stimulates CARP-1 expression. CFM-4 prevents CARP-1 binding with APC-2, causes G 2M cell cycle arrest, and induces apoptosis with an IC 50 range of 10-15 μM. Apoptosis signaling by CFM-4 involves activation of caspase-8 and -9 and caspase-mediated ubiquitin-proteasome pathway-independent loss of cyclin B1 and Cdc20 proteins. Depletion of CARP-1, however, interferes with CFM-4-dependent cell growth inhibition, activation of caspases, and apoptosis. Because CFM-4 also suppresses growth of drug-resistant human breast cancer cells without affecting the growth of human breast epithelial MCF-10A cells, elevating CARP-1 by CFM-4 and consequent apoptosis could in principle be exploited to further elucidate, and perhaps effectively target, often deregulated cell cycle pathways in pathological conditions, including cancer.",
author = "Puliyappadamba, {Vineshkumar Thidil} and Wenjuan Wu and Debra Bevis and Liyue Zhang and Lisa Polin and Robert Kilkuskie and Finley, {Russell L.} and Larsen, {Scott D.} and Edi Levi and Miller, {Fred R.} and Anil Wali and Rishi, {Arun K.}",
year = "2011",
month = "11",
day = "4",
doi = "10.1074/jbc.M111.222398",
language = "English (US)",
volume = "286",
pages = "38000--38017",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "44",

}

TY - JOUR

T1 - Antagonists of Anaphase-promoting Complex (APC)-2-Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis

AU - Puliyappadamba, Vineshkumar Thidil

AU - Wu, Wenjuan

AU - Bevis, Debra

AU - Zhang, Liyue

AU - Polin, Lisa

AU - Kilkuskie, Robert

AU - Finley, Russell L.

AU - Larsen, Scott D.

AU - Levi, Edi

AU - Miller, Fred R.

AU - Wali, Anil

AU - Rishi, Arun K.

PY - 2011/11/4

Y1 - 2011/11/4

N2 - CARP-1/CCAR1, a perinuclear phosphoprotein, is a regulator of cell growth and apoptosis signaling. Although CARP-1 is a regulator of chemotherapy- dependent apoptosis, it is also a part of the NF-κB proteome and a co-activator of steroid/thyroid nuclear receptors as well as β-catenin signaling. Our yeast two-hybrid screen revealed CARP-1 binding with the anaphase-promoting complex/cyclosome E3 ubiquitin ligase component APC-2 protein. CARP-1 also binds with anaphase-promoting complex/cyclosome co-activators Cdc20 and Cdh1. Following mapping of the minimal epitopes involved in CARP-1 binding with APC-2, a fluorescence polarization assay was established that indicated a dissociation constant (K d) of 480 nM for CARP-1/APC-2 binding. Fluorescence polarization assay-based high throughput screening of a chemical library yielded several small molecule antagonists of CARP-1/APC-2 binding, termed CARP-1 functional mimetics. CFM-4 (1(2-chlorobenzyl)-5′-phenyl-3′H-spiro[indoline-3,2′-[1,3,4] thiadiazol]-2-one), a lead compound, binds with and stimulates CARP-1 expression. CFM-4 prevents CARP-1 binding with APC-2, causes G 2M cell cycle arrest, and induces apoptosis with an IC 50 range of 10-15 μM. Apoptosis signaling by CFM-4 involves activation of caspase-8 and -9 and caspase-mediated ubiquitin-proteasome pathway-independent loss of cyclin B1 and Cdc20 proteins. Depletion of CARP-1, however, interferes with CFM-4-dependent cell growth inhibition, activation of caspases, and apoptosis. Because CFM-4 also suppresses growth of drug-resistant human breast cancer cells without affecting the growth of human breast epithelial MCF-10A cells, elevating CARP-1 by CFM-4 and consequent apoptosis could in principle be exploited to further elucidate, and perhaps effectively target, often deregulated cell cycle pathways in pathological conditions, including cancer.

AB - CARP-1/CCAR1, a perinuclear phosphoprotein, is a regulator of cell growth and apoptosis signaling. Although CARP-1 is a regulator of chemotherapy- dependent apoptosis, it is also a part of the NF-κB proteome and a co-activator of steroid/thyroid nuclear receptors as well as β-catenin signaling. Our yeast two-hybrid screen revealed CARP-1 binding with the anaphase-promoting complex/cyclosome E3 ubiquitin ligase component APC-2 protein. CARP-1 also binds with anaphase-promoting complex/cyclosome co-activators Cdc20 and Cdh1. Following mapping of the minimal epitopes involved in CARP-1 binding with APC-2, a fluorescence polarization assay was established that indicated a dissociation constant (K d) of 480 nM for CARP-1/APC-2 binding. Fluorescence polarization assay-based high throughput screening of a chemical library yielded several small molecule antagonists of CARP-1/APC-2 binding, termed CARP-1 functional mimetics. CFM-4 (1(2-chlorobenzyl)-5′-phenyl-3′H-spiro[indoline-3,2′-[1,3,4] thiadiazol]-2-one), a lead compound, binds with and stimulates CARP-1 expression. CFM-4 prevents CARP-1 binding with APC-2, causes G 2M cell cycle arrest, and induces apoptosis with an IC 50 range of 10-15 μM. Apoptosis signaling by CFM-4 involves activation of caspase-8 and -9 and caspase-mediated ubiquitin-proteasome pathway-independent loss of cyclin B1 and Cdc20 proteins. Depletion of CARP-1, however, interferes with CFM-4-dependent cell growth inhibition, activation of caspases, and apoptosis. Because CFM-4 also suppresses growth of drug-resistant human breast cancer cells without affecting the growth of human breast epithelial MCF-10A cells, elevating CARP-1 by CFM-4 and consequent apoptosis could in principle be exploited to further elucidate, and perhaps effectively target, often deregulated cell cycle pathways in pathological conditions, including cancer.

UR - http://www.scopus.com/inward/record.url?scp=80055065140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055065140&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.222398

DO - 10.1074/jbc.M111.222398

M3 - Article

C2 - 21903591

AN - SCOPUS:80055065140

VL - 286

SP - 38000

EP - 38017

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 44

ER -